Atualização | Desafios clínicos do tratamento de infecções por Stenotrophomonas maltophilia. 10 Mai, 2022 | 14:15h Clinical challenges treating Stenotrophomonas maltophilia infections: an update – JAC-Antimicrobial Resistance Conteúdos relacionados: Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach – Open Forum Infectious Diseases Risk Factors for Acquired Stenotrophomonas maltophilia Pneumonia in Intensive Care Unit: A Systematic Review and Meta-Analysis – Frontiers in Medicine Trimethoprim-Sulfamethoxazole versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 U.S. Hospitals – Open Forum Infectious Diseases Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections – Clinical Infectious Diseases